← Back to Screener
USANA Health Sciences Inc (USNA)
Price$20.64
Favorite Metrics
Price vs S&P 500 (26W)-9.73%
Price vs S&P 500 (4W)9.13%
Market Capitalization$375.23M
P/E Ratio (Annual)34.87x
All Metrics
P/CF (Annual)16.79x
Book Value / Share (Quarterly)$29.16
P/TBV (Annual)0.87x
Revenue Growth (3Y)-2.51%
Cash Flow / Share (Quarterly)$0.47
Price vs S&P 500 (YTD)-1.95%
Gross Margin (TTM)78.29%
Net Profit Margin (TTM)1.16%
EPS (TTM)$0.56
10-Day Avg Trading Volume0.11M
EPS Excl Extra (TTM)$0.56
Revenue Growth (5Y)-4.00%
EPS (Annual)$0.58
ROI (Annual)1.97%
Gross Margin (Annual)78.29%
Net Profit Margin (5Y Avg)5.96%
Cash / Share (Quarterly)$8.66
P/E Basic Excl Extra (TTM)34.87x
Revenue Growth QoQ (YoY)6.72%
EPS Growth (5Y)-37.04%
P/E Normalized (Annual)34.87x
ROA (Last FY)1.45%
Revenue Growth TTM (YoY)5.88%
EBITD / Share (TTM)$3.91
ROE (5Y Avg)13.64%
Operating Margin (TTM)4.05%
Cash Flow / Share (Annual)$0.47
P/B Ratio0.70x
P/B Ratio (Quarterly)0.65x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.25x
Net Interest Coverage (TTM)103.00x
ROA (TTM)1.46%
EV / EBITDA (TTM)3.18x
EPS Incl Extra (Annual)$0.58
Current Ratio (Annual)2.24x
Quick Ratio (Quarterly)1.23x
3-Month Avg Trading Volume0.13M
52-Week Price Return-14.38%
EV / Free Cash Flow (Annual)27.08x
P/E Incl Extra (TTM)34.87x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$21.88
P/S Ratio (Annual)0.41x
Asset Turnover (Annual)1.25x
52-Week High$38.32
Operating Margin (5Y Avg)9.41%
EPS Excl Extra (Annual)$0.58
CapEx CAGR (5Y)-1.75%
Tangible BV CAGR (5Y)-0.54%
26-Week Price Return-0.99%
Quick Ratio (Annual)1.35x
13-Week Price Return-2.05%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)2.24x
Enterprise Value$230.85
Revenue / Share Growth (5Y)-1.33%
Asset Turnover (TTM)1.25x
Book Value / Share Growth (5Y)6.75%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.46x
Pretax Margin (Annual)4.49%
Cash / Share (Annual)$8.66
3-Month Return Std Dev44.09%
Gross Margin (5Y Avg)80.49%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-17.49%
EBITDA Interim CAGR (5Y)-26.05%
ROE (Last FY)2.02%
Net Interest Coverage (Annual)50.22x
EPS Basic Excl Extra (Annual)$0.58
P/FCF (TTM)7.98x
Receivables Turnover (TTM)248.40x
EV / Free Cash Flow (TTM)27.08x
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$0.56
Receivables Turnover (Annual)326.57x
ROI (TTM)1.99%
P/S Ratio (TTM)0.41x
Pretax Margin (5Y Avg)9.96%
Revenue / Share (Annual)$49.81
Tangible BV / Share (Annual)$21.88
Forward P/E10.32x
Free OCF CAGR (5Y)-43.29%
Price vs S&P 500 (52W)-49.48%
P/E Ratio (TTM)34.87x
EPS Growth TTM (YoY)-68.53%
Year-to-Date Return2.19%
5-Day Price Return10.40%
EPS Normalized (Annual)$0.58
ROA (5Y Avg)9.79%
Net Profit Margin (Annual)1.16%
Month-to-Date Return14.83%
Cash Flow / Share (TTM)$3.77
EBITD / Share (Annual)$3.90
EPS Growth (3Y)-45.59%
Operating Margin (Annual)4.05%
LT Debt / Equity (Annual)0.09x
P/CF (TTM)16.79x
ROI (5Y Avg)13.56%
P/E Excl Extra (TTM)34.87x
LT Debt / Equity (Quarterly)0.27x
EPS Basic Excl Extra (TTM)$0.56
P/TBV (Quarterly)0.87x
P/B Ratio (Annual)0.65x
Inventory Turnover (TTM)2.46x
Pretax Margin (TTM)4.49%
Book Value / Share (Annual)$29.16
Price vs S&P 500 (13W)-4.92%
Net Margin Growth (5Y)-36.22%
Beta0.83x
P/FCF (Annual)44.01x
Revenue / Share (TTM)$50.60
ROE (TTM)2.03%
52-Week Low$16.60
Analyst Recommendations
Mar 2025
Apr 2025
May 2025
Jun 2025
2.17
2.17
2.17
2.17
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
USNAUSANA Health Sciences Inc | 0.41x | 5.88% | 78.29% | -37.04% | $20.64 |
CRONCronos Group Inc. Common Share | 6.99x | 24.63% | 42.81% | -49.98% | $2.76 |
TLRYTilray Brands, Inc. Common Stock | 0.97x | 3.82% | 27.68% | — | $7.15 |
CGCCanopy Growth Corporation Common Shares | 2.55x | 0.59% | 26.56% | — | $1.20 |
NAGENiagen Bioscience, Inc. Common Stock | 3.01x | 29.95% | 64.28% | — | $4.87 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.54 |
MDWDMediWound Ltd. | 13.35x | -16.14% | 19.19% | — | $17.35 |
ACBAurora Cannabis Inc. Common Shares | 0.77x | 16.54% | 1.35% | — | $3.72 |
BTMDBiote Corp. Class A Common Stock | 0.46x | -2.52% | 71.46% | -26.84% | $2.24 |
FTLFFitLife Brands, Inc. Common Stock | 1.29x | 1.34% | 37.58% | -20.04% | $8.99 |
NAIINatural Alternatives International Inc. | 0.13x | 10.92% | 9.06% | — | $2.76 |
About
USANA Health Sciences Inc develops and manufactures science-based nutritional, personal care, and skincare products focused on long-term health and wellness. The company operates through two segments: direct selling, which generates the majority of revenue across multiple geographic markets, and Hiya, a direct-to-consumer children's health brand in the U.S. These dual channels allow USANA to reach both adult and pediatric wellness markets globally.